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Abstract We have screened protein extracts from chicken
blood cells for acetyltransferases. An in gel acetyltransferase
assay revealed that a 32 kDa protein, which is more prevalent
in whole blood when compared with erythrocyte cells, possessed
an auto-acetylation activity. This protein was puri¢ed by a se-
ries of chromatographic steps, sequenced by Edman degradation
and subsequently identi¢ed as Myb induced myeloid protein
(Mim-1). Mim-1 has similarities to the conserved acetyltrans-
ferase motifs found in the GNAT superfamily of proteins and
also contains three minimal GK acetylation motifs. These data
identify Mim-1 as an acetyltransferase.
+ 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Post-translational modi¢cations of proteins, in particular
phosphorylation and more recently acetylation and methyla-
tion, have been recognised as major mechanisms of regula-
tion. Evidence linking acetylation with active chromatin indi-
cated a key role for such modi¢cations in transcriptional
processes ([1], reviewed in [2]). The importance of acetylation
and its role in gene regulation was underlined by the identi-
¢cation and cloning of the ¢rst histone acetyltransferase Tet-
rahymena p55, a homologue of the yeast transcriptional co-
activator Gcn5 [3]. Gcn5 is contained within the Gcn5-related
N-acetyltransferases (GNAT) superfamily [4]. This family
contains many diverse proteins from di¡erent species, and
these show a degree of homology over a region of approxi-
mately 100 amino acids. Within this region four motifs, A^D,
have been identi¢ed and linked to acetyl-coenzyme A (acetyl-
CoA) binding (A) and enzyme activity (B and D) [4].
Experiments by a number of groups have shown that some
of the histone acetyltransferases could acetylate non-histone
substrates, examples include P/CAF [5] and p300/CBP [6].
Proteins that are modi¢ed include HMG 17 [5], HMG I(Y)
[7], p53 [8], TFIIEL and TFIIF [9], GATA1 [10], EKLF [11]
and K-importin [12]. That such a diverse set of proteins can be
acetylated indicates a broad biological role for acetylation.
Although these proteins can be modi¢ed in vitro by histone
acetyltransferases, the enzymes responsible for their in vivo
acetylation have in many cases not been identi¢ed.
In a series of experiments we screened protein extracts from
chicken blood cells for histone acetyltransferase activities.
This analysis revealed that a protein with a molecular weight
of approximately 32 kDa possessed an auto-acetylation activ-
ity. This protein was extracted, puri¢ed and micro-sequenced.
Sequence analysis identi¢ed the acetyltransferase as Myb in-
duced myeloid protein 1 (Mim-1), a protein that has previ-
ously been described in a number of di¡erent cellular loca-
tions but not identi¢ed as an acetyltransferase or assigned any
biological function.
2. Materials and methods
2.1. Cell and nucleus preparation
Fresh chicken blood was collected into phosphate bu¡ered saline
(PBS) containing 5 mM Na2EDTA, 0.1 mM phenylmethylsulphonyl
£uoride (PMSF) and 0.1 mM benzamidine. Cells were washed once in
PBS followed by two washes in wash bu¡er (10 mM NaCl, 10 mM
Tris^HCl pH 7.5, 6 mM MgCl2, 250 mM sucrose, 0.1 mM PMSF and
0.1 mM benzamidine). The cells were lysed with 45 volumes (packed
cell volume) of cell lysis bu¡er (10 mM NaCl, 10 mM Tris^HCl pH
7.5, 6 mM MgCl2, 250 mM sucrose, 0.2% (v/v) Triton X-100, 0.1 mM
PMSF and 0.1 mM benzamidine) and stirred for 20 min at 4‡C.
Nuclei were collected by centrifugation at 1400Ug. The nuclei were
washed twice in wash bu¡er and collected by centrifugation at
1400Ug. The nuclei were stored in wash bu¡er containing 40% (v/v)
glycerol at 370‡C.
2.2. NaCl extraction
Extraction of acetyltransferases from prepared nuclei was achieved
using a modi¢cation of the method described by Scho«ler et al. [13].
Nuclei were washed and resuspended at a ¢nal concentration of 2 mg/
ml in extraction bu¡er (450 mM NaCl, 20 mM HEPES pH 7.8, 0.5
mM dithiothreitol, 0.2 mM Na2EDTA, 25% (v/v) glycerol, 0.1 mM
PMSF and 0.1 mM benzamidine) and incubated for 30 min at 4‡C
under constant agitation. Following extraction, nuclear debris was
pelleted by centrifugation at 14 000Ug for 5 min at 4‡C. The super-
natant was collected and dialysed overnight against 10 mM sodium
phosphate bu¡er pH 8.0, 10% (v/v) glycerol, 5 mM L-mercaptoetha-
nol, 0.1 mM PMSF and 0.1 mM benzamidine. The sample was cen-
trifuged as above and the supernatant was collected.
2.3. In gel acetyltransferase activity assay
In gel acetyltransferase assays were performed essentially as de-
scribed by Brownell and Allis [14]. Brie£y, identical samples were
loaded onto duplicate SDS polyacrylamide gels. The acetyltransferase
assay gel had calf thymus total histones (Worthington) incorporated
into the gel matrix at a concentration of 0.1 mg/ml. All gels were
electrophoresed under identical conditions, after which the non-his-
tone gel was stained with Coomassie brilliant blue. The two activity
gels, no substrate and histone substrate gels were incubated in bu¡er
A (50 mM Tris^HCl pH 7.9, 1 mM dithiothreitol and 0.1 mM Na-
2EDTA pH 8.0) containing 20% (v/v) isopropanol for a total of 1 h
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with three changes of bu¡er. This was followed by incubation with
bu¡er A for 30 min with three changes of bu¡er. The gels were
denatured by incubation in bu¡er A containing 8 M urea for a total
of 1 h with three changes of bu¡er. The gels were then incubated
overnight in bu¡er A containing 0.04% (v/v) Tween 40 at 4‡C. The
gels were subsequently incubated in bu¡er B (50 mM Tris^HCl pH
7.9, 10 mM Na-butyrate, 10% (v/v) glycerol, 1 mM dithiothreitol and
0.1 mM Na2EDTA pH 8.0) for 40 min with two bu¡er changes. The
gels were then incubated each with 2 ml bu¡er B containing 10 WCi
[3H]acetyl-CoA (2^10 Ci/mmol, Amersham) for 3 h. The gels were
washed in 10% (v/v) acetic acid for 2 h with ¢ve changes of fresh
wash bu¡er. The activity gels were incubated in Amplify (Amersham)
for 30 min and dried down before exposure to ¢lm for approximately
3 weeks.
2.4. Column chromatography
A series of di¡erent chromatography steps were used to isolate the
acetyltransferase. For each of the columns the eluate was continually
monitored at 280 nm and the in gel activity assay was used to trace
the acetyltransferase.
2.4.1. Hydroxyapatite chromatography. Salt extracted proteins
were applied to a 10 ml hydroxyapatite column (Bio-Rad) (pre-equil-
ibrated with 10 mM sodium phosphate bu¡er pH 8.0, 10% (v/v) glyc-
erol, 5 mM L-mercaptoethanol, 0.1 mM PMSF and 0.1 mM benza-
midine) at a £ow rate of 1 ml/min. Bound proteins were eluted using a
linear gradient (10^300 mM) of sodium phosphate.
2.4.2. Q anion exchange column chromatography. The fractions
containing the acetyltransferase from the hydroxyapatite column
were pooled and dialysed against 10 mM NaCl, 10 mM Tris^HCl
pH 7.5, 5 mM L-mercaptoethanol, 0.1 mM PMSF and 0.1 mM ben-
zamidine before loading onto a pre-equilibrated 1 ml Q column (Bio-
Rad) at a rate of 0.5 ml/min. The bound proteins were eluted with a
linear NaCl gradient (10^400 mM NaCl).
2.4.3. S cation exchange chromatography. The £owthrough from
the Q column was dialysed against 10 mM HEPES pH 7.8, 10 mM
NaCl, 10% (v/v) glycerol, 5 mM L-mercaptoethanol, 0.1 mM PMSF
and 0.1 mM benzamidine before loading the sample onto a pre-equil-
ibrated 1 ml S column (Bio-Rad) at a rate of 0.5 ml/min. Proteins
were eluted across a linear NaCl gradient from 10 mM to 400 mM
NaCl at 0.5 ml/min. Fractions of interest were pooled and dialysed
against bu¡er C, 10 mM Tris^HCl pH 7.5, 10% (v/v) glycerol, 5 mM
L-mercaptoethanol, 0.1 mM PMSF and 0.1 mM benzamidine.
2.5. Cyanogen bromide cleavage
A sample of the puri¢ed 32 kDa acetyltransferase was electropho-
resed through a preparative SDS^PAGE gel and the 32 kDa band
excised. The protein was then recovered be electro-elution and dia-
lysed overnight to remove salt before lyophilisation. The protein was
dissolved in 70% (v/v) formic acid and a single crystal of cyanogen
bromide added before incubating for 24 h in the dark for the cleavage
reaction. Following cleavage, the sample was diluted to 6 ml with
dH2O and the sample lyophilised. The sample was resuspended in
1 ml dH2O. This resuspension and freeze drying was repeated for a
total of four times to ensure removal of the formic acid. The ¢nal
pellet was resuspended in SDS loading bu¡er, before electrophoresis
through a 16% SDS polyacrylamide Tris-tricine gel.
2.6. Protein sequencing
Gel separated proteins and peptides were blotted onto polyvinyl-
idene di£uoride (PVDF) membrane (Bio-Rad) and subsequently
stained with Coomassie brilliant blue. The membrane was rinsed
with dH2O, dried and the samples sequenced by Edman degradation
(Alta Bioscience, University of Birmingham).
3. Results
3.1. Isolation and identi¢cation of the acetyltransferase
Proteins were initially extracted from intact chicken blood
cells using a modi¢cation of a freeze thaw method in the
presence of 450 mM NaCl [13]. For this experiment a small
volume, 80 Wl, of loosely packed blood cells was extracted in
200 Wl of high salt bu¡er. Proteins released from the cells into
the supernatant were assayed using the in gel acetyltransferase
assay as described by Brownell and Allis [14]. Fig. 1 shows the
screen for acetyltransferases. The Coomassie stained gels show
the total protein content of the extracts. The £uorographs of
the activity gels show a number of potential acetyltransferase
proteins and their approximate molecular weights. Fig. 1a
shows that a number of proteins in the whole cell extract
have acetyltransferase activity. We decided to purify the ace-
tyltransferase at approximately 32 kDa, which is signi¢cantly
smaller than other acetyltransferases previously described.
We next investigated whether this activity could be ex-
tracted from a crude nuclear preparation. Nuclei were pre-
pared from 30 ml of packed blood cells, and the proteins
extracted. Fig. 1b shows the in gel activity assay of proteins
extracted from the nuclei. The 32 kDa acetyltransferase de-
tected in the whole cell extract is present in the crude nuclear
extracts and is the major acetyltransferase. In addition, we
tested whether the acetyltransferase was present in erythro-
cytes by removing the bu¡y coat containing the white blood
cells at the time of blood preparation. The result of the in gel
activity assay clearly shows that the 32 kDa acetyltransferase
is more abundant in whole blood cells than in the fraction
depleted of white blood cells. Subsequently, all extracts were
Fig. 1. In gel acetyltransferase activity assays of protein extracts. Proteins in the salt extractions were electrophoresed through two 13% SDS^
PAGE gels. One gel was stained with Coomassie brilliant blue, whereas the remaining gel was subjected to an in gel activity assay using his-
tones polymerised into the gel matrix as substrate. The 32 kDa acetyltransferase is marked with an arrowhead. The approximate molecular
masses (kDa) are indicated by the marker proteins (M). a: Proteins extracted from intact chicken blood cells (wb). b: Proteins extracted from
nuclear preparations from either whole blood (wb) or erythrocyte (ery) cells.
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made from whole blood preparations to maximise the yield of
the acetyltransferase.
The protein was puri¢ed from the 450 mM NaCl extract
using a series of chromatography steps, these are summarised
in Fig. 2a. The acetyltransferase was traced throughout the
puri¢cation procedure using the in gel activity assay. Fig. 2b,c
shows the ¢nal stage of the puri¢cation. Proteins that were
eluted in the main peak from the S cation exchange were
pooled and subjected to an in gel activity assay. In this assay
we also included an activity gel without substrate to allow us
to determine whether the protein was capable of auto-acety-
lation. The Coomassie stained gel together with the £uoro-
graph of the in activity gels, with and without histone sub-
strate, is given in Fig. 2c. The Coomassie gel shows that the
32 kDa protein has been highly puri¢ed, as judged by the lack
of other proteins in the sample. The £uorograph shows that
the puri¢ed protein has acetyltransferase activity in both the
histone and no substrate gels.
At a number of di¡erent stages in the puri¢cation process
we were able to blot the partially puri¢ed proteins onto PVDF
membrane and sequence the 32 kDa acetyltransferase. Inter-
nal sequence was also obtained following cyanogen bromide
cleavage of a highly puri¢ed sample. The sequences obtained
are as given in Table 1 and were used to search publicly
available databases. The result of BLAST searches showed
that all of the sequences obtained match a known protein,
Mim-1 [15]. The Mim-1 cDNA was ¢rst identi¢ed by a di¡er-
ential hybridisation screening technique to search for genes
activated by the v-myb oncogene [15]. The cDNA is 1054 bp
in length and encodes a protein of 326 amino acids. The
protein contains two imperfect direct repeats sharing 71%
identity.
3.2. Conserved acetyltransferase domains
Many acetyltransferases are members of the GNAT super-
family of proteins [4]. This family, of which Gcn5 is the ar-
chetypal member, contains proteins from a wide variety of
species. These proteins share a number of common amino
acid sequence motifs A^D [4]. Sub-groups, in particular the
MOZ and Myf family, contain some but not all of the se-
quence motifs. Motif A contains the acetyl-CoA binding do-
main that is present in all family members.
The data presented in Figs. 1^3 demonstrate that Mim-1
has acetyltransferase activity. We therefore examined the ami-
no acid sequence of Mim-1 for similarities to conserved ace-
Fig. 2. Puri¢cation of the 32 kDa acetyltransferase. a: Flow chart showing the chromatography steps used to purify the acetyltransferase. HA
hydroxyapatite, Q anion exchange and S cation exchange chromatography. b: Elution pro¢le from the ¢nal S cation exchange column. c: In
gel activity assay of proteins pooled from the main peak eluted from the S cation exchange column. One gel was stained with Coomassie bril-
liant blue. Duplicate samples were assayed for acetyltransferase activity with either histone or no substrate cast into the resolving gel.
Table 1
Protein sequences obtained by Edman degradation from the 32 kDa
acetyltransferase at various stages in the puri¢cation
Sample Sequence Match
HA fraction HPPQQQGRHWAQIIS Mim-1
Peak S fraction HPPQQ Mim-1
CNBr internal sequence -KVFPGIV Mim-1
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tyltransferase motifs. Sequence comparison revealed similar-
ities between the conserved motifs present in other acetyl-
transferases and repeat 2 of Mim-1 more readily than repeat 1.
Global alignment shows that Mim-1 has 20% identity with
either Gcn5 or Esa-1, which rises to 34% and 36% respectively
allowing for conservative changes (data not shown). The over-
all level of identity between acetyltransferases is not always
high, for example, an alignment of 40 amino acids constitut-
ing the catalytic domains of Gcn5 and Esa-1 shows 23% iden-
tity. The identity of Esa-1 and Mim-1 is 18% whilst Gcn5 and
Mim-1 show 10% identity over the same region.
Further analysis of the Mim-1 sequence reveals similarities
to the motifs A, B and D suggesting that Mim-1 is a member
of the GNAT superfamily. Fig. 3a gives the alignments of the
conserved domains from Gcn5 and Esa-1 with the Mim-1
repeat 2. Neuwald and Landsman [4] used sequence analysis
to identify important conserved amino acids within these mo-
tifs. These are indicated by an asterisk in Fig. 3a. Kuo et al.
[16] used site directed mutagenesis of yeast Gcn5 to detect
those amino acid residues in the active and acetyl-CoA bind-
ing sites that are required for HAT activity, these are shown
as arrows. A number of these conserved and functional resi-
dues are present in the Mim-1.
Close inspection of the alignment between Mim-1 and the
Gcn5 acetyl-CoA binding domain (motif A) shows that out of
the 10 conserved residues (as proposed by Neuwald and
Landsman [4]), Mim-1 shares similarity with six. The same
region of Mim-1 aligned with Esa-1 shows that seven out of
10 conserved amino acid residues are similar. Additionally,
seven of the eight conserved residues in motif B are present
in Mim-1. The identity between Gcn5 and Mim-1 over this
region is 95% allowing for conservative changes. The same
region of Mim-1 aligned to Esa-1 shows that four out of
the eight are similar. In motif D, Mim-1 shares similarity
with four of the six conserved amino acids present in Gcn5
(Esa-1 does not have a comparable domain).
The work of Kuo et al. [16] has shown that certain amino
acids are required for the HAT function of Gcn5, marked
with an arrow in Fig. 3a. Over the acetyl-CoA binding site
(motif A) Mim-1 shares similarities with four out of the eight
amino acids required for HAT activity.
For motif B, Mim-1 shares similarity with all six amino
acids in Gcn5 that are essential for HAT activity [16]. Motif
D also has some similarities with Mim-1, sharing three out of
the six amino acid residues required for activity. Additionally
it was noticed that the catalytic domain of Gcn5 (motif B) lies
upstream of the acetyl-CoA binding site (motif A) at the level
of the primary structure. This orientation is reversed in both
Mim-1 and Esa-1.
Clearly the Mim-1 protein has an acetyl-CoA binding site
and shows similarities with the conserved motifs found within
the GNAT superfamily of acetyltransferases. It should be
noted that very high levels of identity might not be expected
since di¡erent acetyltransferases have di¡erent protein targets,
which could be re£ected in protein sequence variation. For
example, in the bacterial ArgA protein the acetyl-CoA bind-
ing domain contains the sequence SRG where many other
group members have GYG [4]. Mim-1 contains SKG di¡ering
from the ArgA sequence by the conservative change of R
to K.
3.3. Auto-acetylation
The in gel activity assay (Fig. 2) shows the presence of a
band when no substrate is cast into the gel matrix suggesting
that the Mim-1 protein can auto-acetylate. This is not un-
known since Herrera et al. [5] have shown that P/CAF can
auto-acetylate. A number of studies have suggested a weak
consensus sequence GKXXP for acetylation motifs ([8,12,17^
19], reviewed in [20]). Mutational analysis indicates that this
motif could be as small as the two residues, GK [12]. We
therefore examined the Mim-1 sequence for potential GK
acetylation sites and found three minimal GK acetylation
motifs; these are highlighted in Fig. 3b. We note that the
GK sequence is present at the in vivo acetylation sites of his-
tones H2A, H3 and H4. In the gel activity assay, the Mim-1
protein is electrophoresed into a single concentrated band. In
this region of the gel the same protein contains both acetyl-
transferase domains and potential acetylation target sites. It is
therefore understandable that we detect auto-acetylation in
this assay.
Fig. 3. Sequence motifs in Mim-1. a: The schematic representation
of Mim-1 shows the second repeat and the relative positions of the
acetyltransferase motifs B, D and A within repeat 2. Sequence align-
ments of the acetyltransferase motifs of Mim-1 with those of Gcn5
and Esa-1. Similar amino acids are shown in boxes. Asterisks indi-
cate conserved residues in the GNAT family as proposed by Neu-
wald and Landsman [4]. Residues required for histone acetyltrans-
ferase activity of Gcn5 are marked with arrows and are as
described by Kuo et al. [16]. b: Schematic representation of the
Mim-1 protein showing the location of the three potential GK ace-
tylation sites.
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3.4. Is Mim-1 a histone acetyltransferase?
Throughout the puri¢cation procedure the Mim-1 acetyl-
transferase activity was traced by the in gel activity assay.
Because Mim-1 shows a strong auto-acetylation in this assay
it is not possible to determine whether resulting acetylation is
due to histone or auto-acetylation. We therefore tested the
Mim-1 sample eluted from the S column for histone acetyl-
transferase activity using a liquid assay [21]. This highly pu-
ri¢ed Mim-1 was incapable of acetylating histones in this as-
say (data not shown). The Mim-1 protein was puri¢ed using
the S column exploiting the net basic charge of the protein as
previously described [22,23]. However, during the puri¢cation
procedure we noticed that a small proportion (V5%) of Mim-
1, as identi¢ed by sequencing, was retained by the Q column
(see puri¢cation scheme in Fig. 2) and eluted at 175 mM
NaCl. When this fraction was tested in a liquid HAT assay
we found acetylation of histones H4sH3sH2A with free
histones, modulated to H4sH2A with nucleosomal sub-
strates (data not shown). This activity is similar to the yeast
Nu4A acetyltransferase complex [24]. It is attractive to con-
clude that the HAT activity was due to Mim-1, in a protein
complex retained on the Q column. However, we cannot ex-
clude the possibility that the activity is from another acetyl-
transferase, which is present in the same fraction but does not
function in the in gel assay. Further experiments are needed to
test whether Mim-1 can function as a HAT when in an ap-
propriate protein complex.
4. Discussion and conclusions
The data presented here demonstrate that the 32 kDa ace-
tyltransferase detected in protein extracts from chicken blood
cells is the protein Mim-1. This protein is encoded by a gene
spanning 5.8 kb of DNA and contains seven exons. A puta-
tive leader sequence of 23 amino acids has been identi¢ed
which is never seen on mature proteins suggesting post-trans-
lational cleavage. The protein also shows 60% identity (allow-
ing conservative changes) with the 16 kDa human leukocyte
chemotactic protein LECT 2 [25], it is therefore possible that
LECT 2 could also be an acetyltransferase.
The Mim-1 gene is expressed in myeloid cells of the chick-
en haematopoietic system, in particular in myeloblasts and
promyelocytes [15]. Expression is reduced in terminally di¡er-
entiated granulocytes but the protein is stored in large
amounts as granules. Mim-1 can be secreted from virally
transformed cell lines [15] and upon arti¢cially induced exo-
cytosis from chicken polymorphonuclear neutrophils [26].
Another group of workers independently identi¢ed the same
protein [27]. This protein, p33, originally isolated from hen
liver nuclei, was also abundant in chicken heterophils [22]
and was found to be identical to Mim-1 with the exception
of one amino acid. The Mim-1 protein has also been found in
chicken granulocyte preparations and was salt eluted from
nuclei together with the chromatin decompaction protein
Ment [28]. However, it was thought that Mim-1 was present
as a contaminant in nuclear preparations [28]. We have ob-
served that a 32 kDa acetyltransferase is released from 15 day
embryonic nuclei by micrococcal nuclease digestion [21]. Sub-
sequent Western blotting has identi¢ed it as Mim-1 (data not
shown). More recently Mim-1 has been detected in osteo-
clasts and is either secreted, located in the cytoplasm or
found within the peri-nucleus [29]. Further, Falany et al.
[29] have suggested that Mim-1 could be involved in signal-
ling events involved in bone remodelling. Our results demon-
strating that Mim-1 is an acetyltransferase could indicate a
possible role for acetylation and Mim-1 in such signalling
events.
Recently it has been shown that a number of transcription
factors can be acetylated. Acetylation of transcription factors
by histone acetyltransferases has been implicated as a mecha-
nism of control. For example, P/CAF has been shown to
acetylate transcription factors such as p53 [8], TFIIEL and
TFIIF [9], whilst p300/CBP has been shown to acetylate
GATA-1 [10], EKLF [11] and TFIIEL and TFIIF [9]. Imhof
and co-workers [9] have shown that the site of acetylation of
TFIIEL is K52, which lies in a sequence that shows homology
to the amino tail of histone H3. This site has been determined
by site directed mutagenesis of the transcription factor at
K52R. However, p300/CBP can still acetylate TFIIEL with
this amino acid substitution, suggesting a di¡erent site speci-
¢city of this HAT [9]. Interestingly, p300/CBP and P/CAF,
although similar and associated with each other, appear to
have distinct functions. p300/CBP also acetylates GATA-1,
which directly regulates the transcriptional activator function
of GATA-1 in vivo [10]. GATA-1 has a conserved domain of
K/RXKK (where X is any amino acid) in many di¡erent
species suggesting an important regulatory role. This sequence
is also found to be important in p53 [8]. Further work from a
di¡erent group showed that GATA-1 was acetylated at lysine
residues K246 and 252 of one zinc ¢nger and K312 of the
second zinc ¢nger [6]. Acetylation of p53 by P/CAF [8] leads
to increased DNA binding activity, suggesting that acetylation
of p53 leads to an altered conformation of the protein, which
in turn leads to the increased DNA binding activity [8]. In
summary, it has been demonstrated that the function of a
protein may be modulated by acetylation. Our ¢nding that
Mim-1 can auto-acetylate in the in gel assay could suggest a
role for this modi¢cation in its regulation, an important con-
sideration when a protein is relatively abundant and has sev-
eral potential roles.
The key ¢nding of our work is that Mim-1 is an acetyl-
transferase. Mim-1 had been identi¢ed in numerous studies, in
di¡erent circumstances and in many di¡erent cells and cellular
locations. However, a function for the protein has never been
described. Whilst we have been able to de¢ne Mim-1 as an
acetyltransferase, we currently have not yet identi¢ed its in
vivo targets. Mim-1 (p33) was originally classi¢ed as a nuclear
protein, but the presence of a leader sequence would indicate
that it is secreted and may act as a signalling molecule, espe-
cially in the development of chicken blood. A number of
groups have found Mim-1 in nuclear preparations; however,
a nuclear role for Mim-1 as a histone acetyltransferase is
di⁄cult to reconcile with the presence of the leader sequence.
However, we ¢nd that Mim-1 is released from nuclei by the
action of micrococcal nuclease [21]. The presence of a leader
sequence does not always exclude a protein from the nucleus
since human follistatin-related protein, which also contains a
signal sequence, is located within the nuclei of human gran-
ulosa cells [30]. The fact that Mim-1 has been reported in
numerous cellular locations could indicate that it has multiple
roles and multiple targets as is becoming clear for many di¡er-
ent proteins (reviewed in [31]). Work can now proceed to
determine more precisely the role of Mim-1 in di¡erent bio-
logical processes.
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